INTERLEUKIN GENETICS INC 4

4 · INTERLEUKIN GENETICS INC · Filed Jun 19, 2006

Form 4

Period: 2006-06-15

DirectorChief Executive Officer

Transactions

Exercise/Conversion
Common Stock
2006-06-15$0.50/sh+13,500$6,750→ 23,500 total
Sale
Common Stock
2006-06-15$5.14/sh−13,500$69,390→ 10,000 total
Exercise/Conversion
Option to Buy (Common Stock)
2006-06-15+13,500→ 143,500 total
Exercise: $0.50From: 2000-05-01Exp: 2009-05-31→ Common Stock (13,500 underlying)
Exercise/Conversion
Option to Buy (Common Stock)
2006-06-16+26,500→ 117,000 total
Exercise: $0.50From: 2000-07-01Exp: 2009-05-31→ Common Stock (26,500 underlying)
Exercise/Conversion
Common Stock
2006-06-16$0.50/sh+26,500$13,250→ 36,500 total
Sale
Common Stock
2006-06-16$5.06/sh−26,500$134,090→ 10,000 total

Holdings

Footnotes (4)

[F1]Pursuant to a 10b5-1 Trading Plan entered into on May 15, 2006.
[F2]Shares are held in irrevocable trusts for the benefit of Dr. Reilly's children. Dr. Reilly disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the benefical owner of these securities for purposes of Section 16 or any other purposes.
[F3]5,000 of these shares were exercisable on 5/1/00; 8,000 shares were exercisable on 6/1/00; 500 shares were exercisable on 07/1/00.
[F4]7,500 of these shares were exercisable on 7/1/00; 8,000 shares were exercisable on 8/1/00; 8,000 shares were exercisable on 9/1/00; 3,000 shares were exercvisable on 10/1/00.

Documents

1 file